Home
Live Updates
Ligand Pharmaceuticals Shares Rise 21% on 4Q Results Above Estimates : comparemela.com
Ligand Pharmaceuticals Shares Rise 21% on 4Q Results Above Estimates
By Denny Jacob Ligand Pharmaceuticals shares were 21% higher at $89.98 following better-than-expected results in its fourth quarter. The stock is up about...
Related Keywords
Denny Jacob ,
Ligand Pharmaceuticals ,
Article Normal ,
Pharmaceuticals ,
Scientific Research Services ,
Healthcare Life Sciences ,
Business Consumer Services ,
Medical Research Services ,
Drug Discovery Development ,
Healthcare Support Services ,
Diagnostic Medical Research Services ,
Financial Performance ,
Share Price Movement Disruptions ,
Corporate Industrial News ,
Equity Markets ,
Commodity Financial Market News ,
Content Types ,
Factiva Filters ,
C Amp Ampe Exclusion Filter ,
C Amp Ampe Industry News Filter ,
Synd ,
Lgnd ,
Share Price Movement ,
Disruptions ,
Corporate ,
Industrial News ,
Commodity ,
Financial Market News ,
Healthcare ,
Life Sciences ,
Business ,
Consumer Services ,
Drug Discovery ,
Development ,
Diagnostic ,
comparemela.com © 2020. All Rights Reserved.